NASDAQ:NVCR (NovoCure)

About NVCR

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
  • NovoCure (NASDAQ: NVCR) Latest News

    No posts found.